Authors: LINDSAY R COSMAN F CARY DJ LISS CL REAGAN J BYRNES CA MELTON ME PETTY KJ

Citation: R. Lindsay et al., EFFECT OF ALENDRONATE ADDED TO ONGOING HORMONE REPLACEMENT THERAPY INTHE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 41(9), 1998, pp. 575-575

Authors: CARY DJ PETTY KJ LISS C MELTON ME LINDSAY RE

Citation: Dj. Cary et al., PREVALENCE OF LOW BONE MASS USING THE NHANES-III DATABASE IN WOMEN ONESTROGEN THERAPY SCREENED FOR A CLINICAL-TRIAL OF OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 519-519

Authors: PETTY KJ KRIMKEVICH YI THOMAS D

Citation: Kj. Petty et al., A TATA-BINDING PROTEIN-ASSOCIATED FACTOR FUNCTIONS AS A COACTIVATOR FOR THYROID-HORMONE RECEPTORS, Molecular endocrinology, 10(12), 1996, pp. 1632-1645

Authors: WEISS RE HAYASHI Y NAGAYA T PETTY KJ MURATA Y TUNCA H SEO H REFETOFF S

Citation: Re. Weiss et al., DOMINANT INHERITANCE OF RESISTANCE TO THYROID-HORMONE NOT LINKED TO DEFECTS IN THE THYROID-HORMONE RECEPTOR-ALPHA OR BETA-GENES MAY BE DUE TO A DEFECTIVE COFACTOR, The Journal of clinical endocrinology and metabolism, 81(12), 1996, pp. 4196-4203

Authors: PETTY KJ

Citation: Kj. Petty, HYPERGLYCEMIA ASSOCIATED WITH PAROXETINE, Annals of internal medicine, 125(9), 1996, pp. 782-782

Authors: PETTY KJ

Citation: Kj. Petty, TISSUE-SPECIFIC AND CELL-SPECIFIC DISTRIBUTION OF PROTEINS THAT INTERACT WITH THE HUMAN THYROID-HORMONE RECEPTOR-BETA, Molecular and cellular endocrinology, 108(1-2), 1995, pp. 131-142